16:47 EDT Edesa Biotech (EDSA) files $150M mixed securities shelf
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EDSA:
- Edesa Biotech’s ARDS Study: A Breath of Fresh Air for Investors?
- Edesa Biotech Advances ARDS Treatment with JUST BREATHE Study
- Edesa Biotech’s ARDS Trial: A Breath of Fresh Air for Innovative Therapies
- Edesa Biotech’s Promising Future: Buy Rating Backed by EB06’s Potential in Vitiligo Treatment
- Edesa Biotech assumed with a Buy at H.C. Wainwright